Care este prețul pentru Oscotec Inc. (039200)

Prețul pentru Oscotec Inc. (039200) este $24.76

Care este capitalizarea de piață pentru Oscotec Inc. (039200)

Capitalizarea de piață pentru Oscotec Inc. (039200) este $947.10M

Oscotec Inc. (039200) Splituri de Acțiuni

Oscotec Inc. is a biopharmaceutical company specializing in the discovery and development of novel therapeutic drugs. Its primary focus lies in advancing a pipeline of investigational medicines, including a SYK inhibitor currently in Phase IIa clinical trials for the treatment of both rheumatoid arthritis and immune thrombocytopenia. Another key asset is an FLT3 inhibitor, undergoing Phase I clinical evaluation for acute myeloid leukemia. The company is also developing an EGFR double mutation inhibitor aimed at non-small cell lung cancer, and an Anti-Tau antibody in the preclinical stage for Alzheimer's disease. Beyond its pharmaceutical endeavors, Oscotec Inc. diversifies its offerings with a range of dental health products, such as bone graft materials like InduCera, BioCera-F, and SynCeraII, alongside membranes including LysoGide and CollaGuide. Additionally, it markets functional ingredients designed to address specific health concerns, such as OPB for osteoporosis, AIF for arthritis, SGA for enhancing bone growth, and PRF-K for periodontal conditions. Established in 1988, the company, originally known as Oscotec Co., Ltd, adopted its current name, Oscotec Inc., in June 1999. It is headquartered in Seongnam, South Korea.

An	Split	Multiplu	Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.

Split

Multiplu

Multiplu cumulativ

Nu sunt suficiente date pentru perioada selectată.

Companie	Număr total de splituri	Multiplu cumulativ	Țara
Eli Lilly and Company LLY.US	4	x15	US
Johnson & Johnson JNJ.US	7	x432	US
AbbVie Inc. ABBV.US	0	-	US
Roche Holding AG RO.SW	2	x10000	CH
Merck & Co., Inc. MRK.US	7	x226	US

Companie

Număr total de splituri

Multiplu cumulativ

Țara